Cargando…
High national rates of high-dose dopamine agonist prescribing for restless legs syndrome
STUDY OBJECTIVES: Long-term dopamine agonist (DA) use in restless legs syndrome (RLS) is associated with augmentation, a dose-related symptom worsening leading to further dose escalation to manage RLS. This study investigated rates and factors of high-dose DA prescribing in US RLS patients. METHODS:...
Autor principal: | Winkelman, John W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842153/ https://www.ncbi.nlm.nih.gov/pubmed/34417810 http://dx.doi.org/10.1093/sleep/zsab212 |
Ejemplares similares
-
Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial
por: Bogan, Richard K, et al.
Publicado: (2023) -
Striatal histamine mechanism in the pathogenesis of restless legs syndrome
por: Lai, Yuan-Yang, et al.
Publicado: (2019) -
Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
por: Earley, Eric J, et al.
Publicado: (2020) -
Factors associated with augmentation in patients with restless legs syndrome
por: Heim, Beatrice, et al.
Publicado: (2021) -
Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study
por: Roy, Asim, et al.
Publicado: (2023)